Singapore markets close in 5 hours 8 minutes

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.18-1.51 (-9.62%)
At close: 04:00PM EST
14.18 0.00 (0.00%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 2.37B
Enterprise value 2.04B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)489.39
Price/book (mrq)7.60
Enterprise value/revenue 462.82
Enterprise value/EBITDA -6.05

Trading information

Stock price history

Beta (5Y monthly) 1.91
52-week change 3-68.73%
S&P500 52-week change 321.05%
52-week high 356.50
52-week low 312.62
50-day moving average 321.24
200-day moving average 331.20

Share statistics

Avg vol (3-month) 31.87M
Avg vol (10-day) 31.81M
Shares outstanding 5142.94M
Implied shares outstanding 6N/A
Float 8120.38M
% held by insiders 16.79%
% held by institutions 172.30%
Shares short (30 Dec 2021) 415.36M
Short ratio (30 Dec 2021) 45.47
Short % of float (30 Dec 2021) 413.45%
Short % of shares outstanding (30 Dec 2021) 410.75%
Shares short (prior month 29 Nov 2021) 413.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2100:5625
Last split date 329 Apr 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-7,685.09%

Management effectiveness

Return on assets (ttm)-61.92%
Return on equity (ttm)-142.26%

Income statement

Revenue (ttm)4.41M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)5,242.10%
Gross profit (ttm)152k
EBITDA -338.35M
Net income avi to common (ttm)-342.98M
Diluted EPS (ttm)-2.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)356.85M
Total cash per share (mrq)2.72
Total debt (mrq)28.11M
Total debt/equity (mrq)9.02
Current ratio (mrq)4.24
Book value per share (mrq)2.38

Cash flow statement

Operating cash flow (ttm)-260.75M
Levered free cash flow (ttm)-134.1M